Exchange Database

China's pharmaceutical company launches operations in US

Tasly Holding Group, a leading pharmaceutical company in China, officially launched its North American operations in the state of Maryland Wednesday as part of its "go-out" efforts to further expand its business of traditional Chinese medicine overseas. The company, which celebrated its 20th anniversary in May, held a ribbon-cutting ceremony at its office in Rockville, Maryland, to mark the official launch of Tasly Pharmaceuticals as its North American headquarters, with about 150 guests from the Maryland state government and biotechnology and pharmaceutical companies in attendance.
Outcomes: 
"China has been the leader in healing for thousands of years" and Tasly's traditional Chinese medicine "is opening up a whole new chapter of Maryland's life sciences community," said Dominick Murray, Maryland's Business and Economic Development Secretary, adding that they are "excited" to have the new Chinese investment in the state, which is home to more than 500 bioscience companies. The company said it expected the pill to be the first ever multi-herb-based and chemical-free pharmaceutical product approved by the U.S. Food and Drug Administration.
Government?: 
No
Type of Exchange: 
business
education/science
Partners: 
Tasly Holding Group
Maryland state government
Participants (Types): 
150 guests from the Maryland state government and biotechnology and pharmaceutical companies
Exchange Date: 
Wednesday, September 3, 2014
Continuing: 
No
Location: 
Rockville, Maryland
*If you know more about this exchange, please contact us.

Contribute to Database

Please tell us about U.S.-China exchanges that are not yet included in the database.

Commission Report

Polls show Americans and Chinese are becoming less trustful of each other’s country. The Commission assesses the problem and offers recommendations to foster greater U.S.-China collaboration and understanding.

Sign up for our mailing list